Data from 10,000 OHS participants studied for vaccine effectiveness
Feb 8, 2022 // Study Updates
Ontario Health Study investigators merited a $500,000 CIHR operating grant to relate COVID-19 antibody levels to vaccine effectiveness by looking at COVID-19 infection levels, hospitalization rates and deaths in vaccinated OHS participants. They will also assess how immune response to vaccination varies by: Type of vaccine (AstraZeneca, Pfizer or Moderna) including mixed doses Number of
![Photo](https://www.ontariohealthstudy.ca/wp-content/uploads/2021/06/vaccine-5926664_1920.jpg)
Machine learning models using OHS data can help detect risk of Acute Myeloid Leukemia years earlier
Dec 2, 2021 // Study Updates
In this 2021 presentation, Kimberly Skead, a PhD student and coordinator of the Canadian Data Integration Centre, and Philip Awadalla, the Executive Director of the Ontario Health Study, provide insight into why some people develop a type of leukemia while others do not, despite an age-related increase in mutations in blood cells in the European
![Photo](https://www.ontariohealthstudy.ca/wp-content/uploads/2021/12/SkeadVideoTitleCard.png)
CanPath to study the impact and immune response to COVID-19 infection and vaccination
Dec 1, 2021 // Study Updates
The Canadian Partnership for Tomorrow’s Health (CanPath) COVID-19 Antibody Study is expanding. The Government of Canada is investing $1.9 million through Canada’s COVID-19 Immunity Task Force (CITF) to fund an extension of CanPath’s existing study over a longer period of time, allowing for an additional collection of blood samples and questionnaire responses from participants. This
![Photo](https://www.ontariohealthstudy.ca/wp-content/uploads/2021/12/iStock-1292817471-2000px.jpg)
Years-early detection of cancer markers possible through research using OHS samples
Nov 26, 2021 // Study Updates
Plasma samples from 330 OHS participants were used to demonstrate that certain markers in the blood could be used to predict cancers up to seven years before a doctor’s diagnosis. Nicholas Cheng, a PhD student in the Awadalla Lab at the Ontario Institute for Cancer Research, presented his research at the October 2021 American Society
![Photo](https://www.ontariohealthstudy.ca/wp-content/uploads/2021/11/Cheng-Video-title-card.png)